Hymon SARS-CoV-2 Test Kit （supports fast delivery)

    Hymon SARS-CoV-2 Test Kit is produced by HymonBio Co., LTD, which is founded by PhDs from University of Texas & Chinese Academy of Sciences and focus on precision testing on cancer gene screening, epidemic pathogen DNA/RNA tests. Polyhex Technology Co., Ltd. is authorized to marketing development, sales and product support of Hymon SARS-CoV-2 Test Kit overseas from March 13th, 2020 to March 13th, 2021.

    Hymon SARS-CoV-2 Test Kit provides in vitro detection of coronavirus SARS-CoV-2 in nasopharyngeal swab and other respiratory samples. The virus infects human and caused COVID-19.

    The test applies proprietary MoLock, a nanobody-based probe technology, and OT, a buffer system technology, to build the multiplexing RT-PCR kit that targets N and E genes of SARS-CoV-2 to achieve ultrasensitive and robust detection of viral RNA in a same-tube, sample-to-result process. With overall turnaround time at 1.5 hours for 96 tests, the kit offers 5 copies/PCR detection limit of SARS-CoV-2 with high specificity and maintains a consistent quality with an internal control. Hymon SARS-CoV-2 Test Kit provides references to key clinical decisions such as confirmation of early infection, evaluation of therapeutic efficacy, and determination of negative conversion.

Features:

• High accuracy

• High cost performance

• Quickly detect the Coronavirus infection

• Quickly evaluate the Coronavirus treatment effect

• Already applied in Wuhan, Nanjing, Xi'an and other major cities in China.

• Clinical sample quality control test report available (Shanghai Clinical Laboratory Center)

• Fast delivery (Certificates for exportation and sale transport of chemical goods are available)